Executive Summary & Synergistic Formulation Chemistry
A precisely engineered combination premix delivering complementary anticoccidial action against all pathogenic avian Eimeria species while overcoming single-entity resistance and lowering host toxicity.
Nicarbazin 8% + Maduramycin 0.75% Premix (officially designated as Compound Maduramicin Ammonium Premix in the Chinese Veterinary Pharmacopoeia) is a scientifically balanced veterinary anticoccidial premix. By combining the chemical carbanilide agent Nicarbazin (8.0% w/w, 80 g/kg; CAS 330-95-0) with the potent monovalent glycoside polyether ionophore Maduramicin Ammonium (0.75% w/w, 7.5 g/kg; CAS 84878-61-5) on a defatted carrier, this premix achieves multiplicative synergy against poultry coccidiosis.
The strategic combination of an ionophore and a chemical anticoccidial eliminates field resistance that routinely plagues monotherapy regimens. Crucially, the synergistic multiplication allows active inclusion rates to be reduced by more than 50% compared to single-agent administration: Maduramicin is delivered at 3.75 ppm (vs. 5 ppm monotherapy) and Nicarbazin is delivered at 40 ppm (vs. 125 ppm monotherapy). This wider safety margin protects broiler performance and eliminates the thermal distress and growth suppression traditionally associated with high-dose nicarbazin use.
Key Strategic Advantages in Commercial Poultry Operations
Engineered for large-scale broiler integrators and commercial feed mills seeking maximum anticoccidial efficacy with low host stress.
Dual Synergistic Potency
Synergistic multiplication yields a higher Anticoccidial Index (ACI) than either compound fed alone, destroying parasites at lower drug concentrations.
Resistance Breakthrough
Combining distinct biochemical target sites circumvents field tolerance and prevents the development of single-drug resistance during intense growing cycles.
Broad-Spectrum Control
Full protection across all major pathogenic Eimeria strains: E. tenella, E. acervulina, E. maxima, E. necatrix, E. brunetti, E. mitis, and E. praecox.
Broadened Safety Margin
Reduced active levels safeguard flock growth, eliminate heat-stress mortality in summer, and provide safety headroom against accidental batch fluctuations.
Two-Phase Biological Mode of Action (MOA)
Sequential lifecycle disruption intercepts Eimeria parasites across both early motile invasion and late asexual replication stages.
Phase 1: Sporozoite Osmotic Lysis
Maduramicin acts on Day 1–2 of infection. As an ionophore, it shuttles monovalent Na+ and K+ across sporozoite and trophozoite cell membranes, forcing continuous ATP exhaustion via the Na+/K+-ATPase pump, resulting in osmotic swelling and cytolysis.
Phase 2: Schizont Metabolic Arrest
Nicarbazin acts on Day 3–4 of infection. It selectively targets second-generation schizonts, inhibiting mitochondrial oxidative phosphorylation, ATP synthesis, and purine metabolism, preventing merozoite maturation and tissue invasion.
Phase 3: Epithelial Mucosal Defense
By destroying coccidial parasites before extensive intestinal desquamation, the premix preserves enterocyte microvilli structure, prevents blood loss, suppresses secondary Clostridium perfringens necrotic enteritis, and protects FCR.
Phase 4: Predictable Elimination
Active ingredients exhibit targeted gastrointestinal distribution with enterohepatic cycling, ensuring continuous gut lumen presence during the feeding phase and rapid systemic clearance within the 7-day withdrawal window.
Technical Specifications & Quality Release Standard
Manufactured in strict compliance with the Chinese Veterinary Pharmacopoeia (CPV 2020) and international feed safety guidelines.
| Test Parameter | Pharmacopoeia Specification Standard | Typical Batch Actual Result | Analytical Methodology |
|---|---|---|---|
| Active Content: Nicarbazin | 7.20% – 8.80% w/w (90.0% – 110.0% of label) | 8.06% w/w (100.8% of label) | UV-Vis Spectrophotometry (430 nm) |
| Active Content: Maduramicin | 0.675% – 0.825% w/w (90.0% – 110.0% of label) | 0.761% w/w (101.5% of label) | HPLC-RI (CPV Appendix 0512) |
| Physical Appearance | Yellow to brownish-yellow or brown fine powder | Conforms (Brownish-yellow powder) | Organoleptic / Visual Inspection |
| Identification (HPLC & UV) | HPLC retention time matches RS; UV max at 430 nm | Conforms (Both tests positive) | HPLC & UV-Vis (CPV Monographs) |
| Particle Size (Sieve No. 2, ~850 um) | Passing rate ≥ 95.0% | 98.8% passing rate | ChP Appendix 0982 Sieving Method |
| Fine Powder Limit (Sieve No. 5, ~180 um) | Passing rate ≤ 10.0% | 4.6% passing rate | ChP Appendix 0982 Sieving Method |
| Loss on Drying (60 deg C, P2O5, 4h) | ≤ 10.0% | 4.5% | Gravimetric (CPV Appendix 0831) |
| Carrier Dispersion Uniformity (CV) | Coefficient of Variation ≤ 5.0% | Conforms (CV = 3.2%) | Multi-point High Accuracy Assay |
| Heavy Metals (as Pb) | ≤ 20 mg/kg | < 10 mg/kg | ICP-OES / Atomic Absorption |
Feed Inclusion, Dosage & Administration Guidelines
Accurate feed mill blending instructions to ensure perfect batch homogeneity and consistent bird intake.
Commercial Inclusion Rate
Mix 500 g of premix per 1,000 kg of complete poultry feed. Delivers 40 ppm (40 g/MT) Nicarbazin active and 3.75 ppm (3.75 g/MT) Maduramicin active into finished feed.
Target Flock & Feeding Duration
Indicated for broiler chickens. Administer continuously for 5 to 7 consecutive days during coccidiosis outbreaks, or feed throughout the starter-grower phase in shuttle programs.
Two-Step Pre-dilution Protocol
To guarantee uniform micro-ingredient distribution, blend 500 g of premix with 10–25 kg of grain flour or fine feed carrier before adding to the main batch mixer.
Safety Precautions, Contraindications & Storage Conditions
Critical veterinary precautions to ensure bird welfare, residue compliance, and maximum product stability.
- Strict Withdrawal Period: Broiler chickens must observe a strict 7-day withdrawal period prior to slaughter to guarantee zero tissue residues.
- Laying Hens & Breeders Contraindicated: Strictly prohibited in commercial laying hens during egg production and breeding flocks. Nicarbazin adversely affects eggshell quality, yolk color, egg drop, and embryo hatchability.
- Narrow Safety Index for Maduramicin: Maduramicin Ammonium has a narrow therapeutic safety window; dietary levels of 7 mg/kg or above can cause severe toxicity, paralysis, and mortality. Do not overdose.
- Ionophore Compatibility Alert: Do not co-administer with tiamulin or combine with other polyether ionophores (such as monensin, salinomycin, lasalocid, or narasin) to prevent fatal toxic reactions.
- Hot Weather Management: Exercise caution during high-temperature and humid seasons. Ensure adequate tunnel ventilation, cool drinking water, and reduced stocking density to avoid heat-stress complications.
- Storage & Packaging: Store in tightly sealed original packaging, protected from light, moisture, and extreme heat in a well-ventilated dry warehouse. Standard packaging: 25 kg multi-wall craft paper bags or fiber drums with PE inner lining. Shelf life: 24 months.
Strategic Biosecurity: Rotation & Shuttle Coccidiosis Programs
How to integrate Nicarbazin 8% + Maduramycin 0.75% Premix into comprehensive farm biosecurity strategies.
Starter-to-Grower Shuttle
Utilize Nicarbazin + Maduramicin Premix in the early starter feed (Day 1–21) to block early oocyst shedding, followed by an ionophore monotherapy (e.g., Salinomycin or Monensin) or chemical anticoccidial in the grower feed.
Seasonal Rotation Strategy
Deploy this potent combination premix during high-challenge cool and moderate seasons (Autumn through Spring), alternating to non-nicarbazin formulations during extreme peak summer months to eliminate heat stress risks.
Resistance Cleanup Phase
When poultry complexes observe breakthrough coccidiosis lesions under long-term single ionophore programs, introduce Nicarbazin 8% + Maduramycin 0.75% for 1–2 grow-out cycles to restore farm biosecurity baselines.
Necrotic Enteritis Control
By stopping subclinical E. maxima and E. acervulina gut wall disruption, the premix denies Clostridium perfringens the necessary necrotic tissue niche, dramatically lowering enteritis incidence and medication costs.
Frequently Asked Questions (Technical & Commercial FAQ)
Key answers for poultry veterinary nutritionists, feed formulators, and farm biosecurity managers.
Q1: Why is this combination more effective than feeding Maduramicin or Nicarbazin alone?
Single-agent coccidiostats operate on only one biological pathway, allowing tolerant parasite sub-populations to survive and multiply. By combining an ionophore (disrupting monovalent cation pumps in early sporozoites) with a chemical inhibitor (blocking mitochondrial respiration in second-generation schizonts), this premix achieves a multiplicative synergistic kill, halting parasite development at multiple lifecycle checkpoints.
Q2: How does this formulation overcome the traditional heat stress issues of nicarbazin?
Pure nicarbazin monotherapy requires 125 ppm active ingredient in feed, which can interfere with bird thermoregulation during hot weather. Because of the synergistic multiplication with maduramicin, the required nicarbazin active concentration is reduced to only 40 ppm (a 68% reduction), dramatically widening bird thermal tolerance while retaining superior coccidiosis control.
Q3: What are the carrier characteristics and mixing stability in commercial feed mills?
The premix is formulated on high-density, defatted corn cob meal carrier calibrated to Chinese Standard Sieve specifications (passing Sieve No. 2 ≥ 95%, Sieve No. 5 ≤ 10%). This controlled granulation prevents electrostatic dust segregation and delivers rapid, homogeneous blending (CV ≤ 5.0%) across all standard horizontal and vertical batch feed mixers.
Q4: What is the official withdrawal period and international residue standard?
In compliance with the Chinese Veterinary Pharmacopoeia and international veterinary authority standards, the required withdrawal period is 7 days before slaughter in chickens. When the 7-day withdrawal period is maintained, muscle and liver tissues conform strictly to international Maximum Residue Limits (MRLs).
Procure Certified Nicarbazin 8% + Maduramycin 0.75% Premix Directly from Well Sunshine
Direct factory supply with full CPV batch test release certificates, export documentation, and professional technical support for poultry integrators and premix manufacturers worldwide.
Hot Tags: nicarbazin 8%+maduramycin 0.75%, manufacturers, suppliers, factory, wholesale, custom, coccidia medicine for dogs, preventing coccidiosis in chickens, Nicarbazin 8 Monensin Sodium 8 , coccidiosis in calves, coccidiosis in ducks, Maduramycin Ammonium 1
Nicarbazin 8%+Maduramycin 0.75% Premix
Active Ingredient: Maduramycin Ammonium and Nicarbazine.
Specification: Nicarbazin 8%+Maduramycin 0.75%
Characteristics: Yellow or yellow-green granular.
Indications:
Anti-coccidiosis, for the prevention of chicken coccidiosis.
Pharmacology:
Maduramycin Ammonium plays a role in the 48h before coocidia's asexual reproduction, killing coccidia's sporozoite, trophozoites and the first generation schizonts. It could disrupt membrane's active transport capacity of Na+ and K+ in coccidia, to make coccidia energy lacking and death. Nicarbazine kills the second-generation schizonts and trophozoites, reducing intestinal cell damage.
The two ingredients have different pharmacological effects and they will have a pecial anti-coccidia effect when using together.
Precautions:
- Nicarbazin 8%+Maduramycin 0.75% Premix is highly toxic, so forbid using in other animals in addition to chicken.
- The safe range of this product is narrow. And it will inhibit the growth of broiler chickens if feed concentration of Maduramycin is more than 6 mg/kg.
- Forbid using in laying chicken.
- Be more careful when using in the high temperature season.
- Forbid using directly. It should be made into premix or solution, and mixed evenly with feed before using.
Withdrawal Period: 9 days.
Package: 25 kg/bag.
Storage: Store in a cool and dry place, in sealed or closed container.
Expiry: Two years.







